Natera (NTRA) Competitors $165.71 +3.24 (+1.99%) Closing price 04:00 PM EasternExtended Trading$165.68 -0.03 (-0.02%) As of 07:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NTRA vs. HIMS, GH, RDNT, OPCH, SHC, BTSG, WGS, CON, SGRY, and PRVAShould you be buying Natera stock or one of its competitors? The main competitors of Natera include Hims & Hers Health (HIMS), Guardant Health (GH), RadNet (RDNT), Option Care Health (OPCH), Sotera Health (SHC), BrightSpring Health Services (BTSG), GeneDx (WGS), Concentra Group Holdings Parent (CON), Surgery Partners (SGRY), and Privia Health Group (PRVA). These companies are all part of the "healthcare" industry. Natera vs. Its Competitors Hims & Hers Health Guardant Health RadNet Option Care Health Sotera Health BrightSpring Health Services GeneDx Concentra Group Holdings Parent Surgery Partners Privia Health Group Natera (NASDAQ:NTRA) and Hims & Hers Health (NYSE:HIMS) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, media sentiment, analyst recommendations, dividends, earnings and profitability. Does the media favor NTRA or HIMS? In the previous week, Hims & Hers Health had 51 more articles in the media than Natera. MarketBeat recorded 77 mentions for Hims & Hers Health and 26 mentions for Natera. Natera's average media sentiment score of 1.45 beat Hims & Hers Health's score of 0.31 indicating that Natera is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Natera 21 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Hims & Hers Health 17 Very Positive mention(s) 6 Positive mention(s) 44 Neutral mention(s) 5 Negative mention(s) 2 Very Negative mention(s) Neutral Do insiders & institutionals believe in NTRA or HIMS? 99.9% of Natera shares are held by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are held by institutional investors. 5.6% of Natera shares are held by company insiders. Comparatively, 17.7% of Hims & Hers Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Which has stronger earnings & valuation, NTRA or HIMS? Hims & Hers Health has lower revenue, but higher earnings than Natera. Natera is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNatera$1.70B13.40-$190.43M-$1.91-86.76Hims & Hers Health$1.48B6.97$126.04M$0.8056.88 Is NTRA or HIMS more profitable? Hims & Hers Health has a net margin of 9.63% compared to Natera's net margin of -12.89%. Hims & Hers Health's return on equity of 26.26% beat Natera's return on equity.Company Net Margins Return on Equity Return on Assets Natera-12.89% -22.22% -15.03% Hims & Hers Health 9.63%26.26%13.06% Which has more risk and volatility, NTRA or HIMS? Natera has a beta of 1.76, indicating that its share price is 76% more volatile than the S&P 500. Comparatively, Hims & Hers Health has a beta of 2.08, indicating that its share price is 108% more volatile than the S&P 500. Do analysts rate NTRA or HIMS? Natera currently has a consensus target price of $193.19, indicating a potential upside of 16.58%. Hims & Hers Health has a consensus target price of $38.92, indicating a potential downside of 14.48%. Given Natera's stronger consensus rating and higher probable upside, equities research analysts plainly believe Natera is more favorable than Hims & Hers Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Natera 0 Sell rating(s) 0 Hold rating(s) 17 Buy rating(s) 1 Strong Buy rating(s) 3.06Hims & Hers Health 3 Sell rating(s) 8 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 1.92 SummaryHims & Hers Health beats Natera on 9 of the 17 factors compared between the two stocks. Get Natera News Delivered to You Automatically Sign up to receive the latest news and ratings for NTRA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NTRA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NTRA vs. The Competition Export to ExcelMetricNateraMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$22.30B$7.71B$5.74B$9.75BDividend YieldN/A2.75%3.95%4.07%P/E Ratio-86.7676.7430.3326.09Price / Sales13.4050.20462.11120.66Price / CashN/A24.4437.7259.08Price / Book18.2523.279.776.67Net Income-$190.43M$242.04M$3.27B$265.43M7 Day Performance3.49%0.02%3.95%3.11%1 Month Performance19.30%-0.71%3.81%0.39%1 Year Performance40.30%8.50%31.26%18.52% Natera Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NTRANatera3.121 of 5 stars$165.71+2.0%$193.19+16.6%+32.4%$22.30B$1.70B-86.764,434Positive NewsHIMSHims & Hers Health2.7529 of 5 stars$45.15-1.9%$38.92-13.8%+157.2%$10.20B$1.48B56.441,637Trending NewsInsider TradeGHGuardant Health3.2887 of 5 stars$59.47+1.0%$57.50-3.3%+113.2%$7.42B$739.02M-17.752,021Positive NewsRDNTRadNet3.2381 of 5 stars$66.29-1.7%$71.60+8.0%+7.1%$5.10B$1.83B-331.4311,021Positive NewsOPCHOption Care Health4.8395 of 5 stars$28.19-0.5%$35.75+26.8%-11.8%$4.57B$5.00B22.558,088Positive NewsSHCSotera Health1.4015 of 5 stars$15.80+0.4%$16.00+1.3%+6.3%$4.49B$1.10B197.523,000Positive NewsInsider TradeBTSGBrightSpring Health Services1.7557 of 5 stars$23.09+2.9%$25.67+11.2%+91.6%$4.09B$11.27B74.4935,000News CoveragePositive NewsWGSGeneDx2.1747 of 5 stars$125.90-0.4%$101.63-19.3%+240.8%$3.62B$305.45M2,518.001,200CONConcentra Group Holdings Parent2.2801 of 5 stars$22.85-1.7%$28.50+24.8%-0.2%$2.93B$1.90B19.2011,250News CoveragePositive NewsSGRYSurgery Partners2.9783 of 5 stars$22.49-1.4%$33.00+46.7%-31.6%$2.88B$3.11B-15.7315,000Positive NewsPRVAPrivia Health Group3.6566 of 5 stars$21.37+0.5%$28.00+31.0%+2.6%$2.62B$1.74B194.291,140News CoveragePositive News Related Companies and Tools Related Companies HIMS Competitors GH Competitors RDNT Competitors OPCH Competitors SHC Competitors BTSG Competitors WGS Competitors CON Competitors SGRY Competitors PRVA Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NTRA) was last updated on 8/26/2025 by MarketBeat.com Staff From Our PartnersFed Decision Warning: How to Protect Your Wealth Before September 30th On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the...American Alternative | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredCover all your expenses with just $118,000 invested?Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...Investors Alley | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Natera, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Natera With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access